Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Shares Outstanding (Diluted Average): 2011-2012

  • EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) rose 6.68% to $20.8 million in Q2 2012 from the same period last year, while for Jun 2012 it was $20.8 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $20.8 million for FY2012, which is 6.68% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Shares Outstanding (Diluted Average) of $20.8 million as of Q2 2012, which was up 6.68% from $19.5 million recorded in Q2 2011.
  • In the past 5 years, EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $20.8 million in Q2 2012 and a low of $19.5 million during Q2 2011.
  • For the 2-year period, EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $20.1 million, with its median value being $20.1 million (2011).
  • Data for EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY rose of 6.68% (in 2012) over the last 5 years.
  • Over the past 2 years, EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $19.5 million in 2011, then increased by 6.68% to $20.8 million in 2012.